Developmental studies in fragile X syndrome.
Razak, KA; Dominick, KC; Erickson, CA.
Journal of Neurodevelopmental Disorders.
2020;
12.
Recent Advances in the Pharmacological Management of Behavioral Disturbances Associated with Autism Spectrum Disorder in Children and Adolescents.
Lamy, M; Pedapati, EV; Dominick, KL; Wink, LK; Erickson, CA.
Pediatric Drugs.
2020;
22:473-483.
Examination of correlates to health-related quality of life in individuals with fragile X syndrome.
Coffman, MC; Shaffer, RC; Schmitt, LM; Dominick, KC; Pedapati, E; Wang, A; Berry-Kravis, E; Tartaglia, N; Erickson, CA.
Brain Sciences.
2020;
10:213-213.
Pediatric Quality of Life Inventory (PedsQL) in Fragile X Syndrome.
Fitzpatrick, SE; Schmitt, LM; Adams, R; Pedapati, EV; Wink, LK; Shaffer, RC; Sage, J; Weber, JD; Dominick, KC; Erickson, CA.
Journal of Autism and Developmental Disorders.
2020;
50:1056-1063.
Atypical Social Attention and Emotional Face Processing in Autism Spectrum Disorder: Insights From Face Scanning and Pupillometry.
Reisinger, DL; Shaffer, RC; Horn, PS; Hong, MP; Pedapati, EV; Dominick, KC; Erickson, CA.
Frontiers in Integrative Neuroscience.
2020;
13.
The relationship between expressive language sampling and clinical measures in fragile X syndrome and typical development.
Shaffer, RC; Schmitt, L; Thurman, AJ; Abbeduto, L; Hong, M; Pedapati, E; Dominick, K; Sweeney, J; Erickson, C.
Brain Sciences.
2020;
10:66-66.
Differentiating social preference and social anxiety phenotypes in fragile X syndrome using an eye gaze analysis: a pilot study.
Hong, MP; Eckert, EM; Pedapati, EV; Shaffer, RC; Dominick, KC; Wink, LK; Sweeney, JA; Erickson, CA.
Journal of Neurodevelopmental Disorders.
2019;
11.
Pharmacologic Interventions for Irritability, Aggression, Agitation and Self-Injurious Behavior in Fragile X Syndrome: An Initial Cross-Sectional Analysis.
Eckert, EM; Dominick, KC; Pedapati, EV; Wink, LK; Shaffer, RC; Andrews, H; Choo, T; Chen, C; Kaufmann, WE; Tartaglia, N; et al.
Journal of Autism and Developmental Disorders.
2019;
49:4595-4602.
Peripheral Amyloid Precursor Protein Derivative Expression in Fragile X Syndrome.
McLane, RD; Schmitt, LM; Pedapati, EV; Shaffer, RC; Dominick, KC; Horn, PS; Gross, C; Erickson, CA.
Frontiers in Integrative Neuroscience.
2019;
13.
A Pilot Quantitative Evaluation of Early Life Language Development in Fragile X Syndrome.
Reisinger, DL; Shaffer, RC; Pedapati, EV; Dominick, KC; Erickson, CA.
Brain Sciences.
2019;
9:27-27.